R.K. Bhamra

Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study

K. Mross, Bernward Niemann, Ulrich Massing et al. · Cancer Chemotherapy and Pharmacology · 2004 · 135 citations

Medicine, Pharmacokinetics, Pharmacology +11

Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer

Christine E. Swenson, Lois E. Bolcsak, Gerald Batist et al. · Anti-Cancer Drugs · 2003 · 115 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

High performance liquid chromatographic analysis of basic drugs on silica columns using non-aqueous ionic eluents

Robert J. Flanagan, G. Storey, R.K. Bhamra et al. · Journal of Chromatography A · 1982 · 100 citations

Pharmacy, Chemistry, Pharmaceutical Analysis +13

Paediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics.

Jan Till, E A Shinebourne, Edward Rowland et al. · Heart · 1989 · 46 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

High-performance liquid chromatographic method for the measurement of mexiletine and flecainide in blood plasma or serum

R.K. Bhamra, Robert J. Flanagan, David W. Holt · Journal of Chromatography B Biomedical Sciences and Applications · 1984 · 39 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +13